Live Breaking News & Updates on Carsten Brockmeyer

Stay updated with breaking news from Carsten brockmeyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DGAP-News: Formycon publishes Update on Development Projects

DGAP-News: Formycon AG / Key word(s): Miscellaneous/Miscellaneous Formycon publishes Update on Development Projects 17.06.2022. ....

United States , United Kingdom , Carsten Brockmeyer , Johannes Buchner , Ulrike Protzer , Nicola Mikulcik , Stefan Glombitza , Coherus Biosciences Inc , Cell Therapy Ltd , Paul Ehrlich Institute , Teva Pharmaceutical Industries Ltd , Technical University Of Munich , British Medicines Agency , Committee For Medicinal Products Human Use , Regeneron Pharmaceuticals Inc , Drug Administration , European Commission , Genentech Inc , Regulatory Agency , Corporate Communications , European Medicines Agency , Press Release , Development Projects , Ehrlich Institute , Teva Pharmaceutical Industries , Medicinal Products ,

DGAP-Adhoc: Formycon announces changes to its Executive Board

DGAP-Ad-hoc: Formycon AG / Key word(s): Personnel/Miscellaneous Formycon announces changes to its Executive Board 19-May-2022 / 08:50 CET/CES. ....

Carsten Brockmeyer , Andreas Seidl , Stefan Glombitza , Nicola Mikulcik , Corporate Communications , Scientific Affairs , Market Scale Of The Frankfurt Stock Exchange , Business Development , Hoc Announcement , Supervisory Board , Chief Operating Officer , Chief Executive Officer , Executive Board , Chief Business Officer , Chief Scientific Officer , Chief Financial Officer , Nicolas Comb , Open Market , Frankfurt Stock Exchange , Manager Corporate Communications ,

Formycon announces changes to its Executive Board

19.05.2022 Formycon announces changes to its Executive Board | Formycon AG | News | Nachricht | Mitteilung ....

Carsten Brockmeyer , Andreas Seidl , Stefan Glombitza , Nicola Mikulcik , Corporate Communications , Scientific Affairs , Market Scale Of The Frankfurt Stock Exchange , Business Development , Hoc Announcement , Supervisory Board , Chief Operating Officer , Chief Executive Officer , Executive Board , Chief Business Officer , Chief Scientific Officer , Chief Financial Officer , Nicolas Comb , Open Market , Frankfurt Stock Exchange , Manager Corporate Communications , D Hoc ,

Investegate |Formycon AG Announcements | Formycon AG: Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG

Investegate announcements from Formycon AG, Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG ....

United States , Frankfurt Am Main , Carsten Brockmeyer , Wendeln Cie , Bioeq Gmb , Stefan Glombitza , Melissa Simon , Florian Bamberg , Aristo Pharma Gmb , Bioeq Gmbh , Genentech Inc , Research Development , Strategic Communications , Santo Holding Gmb , Corporate Communications , Formycon Group , Press Release , Santo Holding Gmbh , Aristo Pharma Gmbh , Nicolas Comb , Active Ownership Capital , Executive Board , Supervisory Board , Active Ownership , Audio Webcast , Manager Corporate Communications ,

Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the

DGAP-News: Formycon AG / Key word(s): Mergers & Acquisitions/Agreement29.03.2022 / 18:02 The issuer is solely responsible for the content of this announcement.Press Release // March 29, 2022Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of bio. ....

United States , Frankfurt Am Main , Carsten Brockmeyer , Wendeln Cie , Bioeq Gmb , Stefan Glombitza , Melissa Simon , Florian Bamberg , Aristo Pharma Gmb , Bioeq Gmbh , Genentech Inc , Research Development , Distribution Services , Strategic Communications , Santo Holding Gmb , Corporate Communications , Formycon Group , Santo Holding Gmbh , Aristo Pharma Gmbh , Nicolas Comb , Active Ownership Capital , Executive Board , Supervisory Board , Active Ownership , Audio Webcast , Manager Corporate Communications ,